1.Questions Surrounding iPS Cells in Japan.
International Journal of Stem Cells 2016;9(1):1-2
No abstract available.
Induced Pluripotent Stem Cells*
;
Japan*
2.Research advances in induced pluripotent stem cells.
Acta Academiae Medicinae Sinicae 2011;33(4):456-461
Differentiated somatic cells can be directly reprogrammed into induced pluripotent stem (iPS) cells in vitro. Similarly to embryonic stem (ES) cells, iPS cells have pluripotency to differentiate into all cell types and capability to self-renew themselves indefinitely. Without immune rejection and ethical issues, patient-specific iPS cells promise to be an ideal tool for regenerative medicine, drug screening, and toxicity testing.
Humans
;
Induced Pluripotent Stem Cells
4.Highly Efficient Reprogramming and Characterization of Induced Pluripotent Stem Cells by Using a Microwell Array.
Hyun LEE ; Gyu Man KIM ; Jin Ho CHOI ; Min Hee PARK ; Jae sung BAE ; Hee Kyung JIN
Tissue Engineering and Regenerative Medicine 2016;13(6):691-700
Reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) enables the possibility of generating patient-specific cells. However, the low efficiency issue associated with iPSCs generation has limited iPSCs usage in research and clinical applications. In this study, we developed a high efficiency system to generate iPSCs by using a polydimethylsiloxane stencil. This device could be applied to the localization and reprogramming of human fibroblasts. Herein, a well-defined culture system based on a stencil, which supported efficient reprogramming of fibroblasts into iPSCs with 2–4 fold increase in efficacy over conventional methods, is presented. Subsequently, we prepared a multiple analysis system, which used a micro-patterned scissile microarray to characterize iPSCs. The results showed that iPSCs could be cultured into micro-patterns in a precisely controlled manner on the scissile poly(ethylene terephthalate) sheet, which was cut into pieces for subsequent analyses, indicating that this method allows multiple analyses to establish iPSC pluripotency in the same sample. Our approach provides a simple, cost-effective, but highly efficient system for the generation and characterization of iPSCs, and will serve as a powerful tool for establishing patient- and disease-specific pluripotent stem cells.
Fibroblasts
;
Humans
;
Induced Pluripotent Stem Cells*
;
Methods
;
Pluripotent Stem Cells
6.Progress in stem cells and regenerative medicine.
Libin WANG ; He ZHU ; Jie HAO ; Qi ZHOU
Chinese Journal of Biotechnology 2015;31(6):871-879
Stem cells have the ability to differentiate into all types of cells in the body and therefore have great application potential in regenerative medicine, in vitro disease modelling and drug screening. In recent years, stem cell technology has made great progress, and induced pluripotent stem cell technology revolutionizes the whole stem cell field. At the same time, stem cell research in our country has also achieved great progress and becomes an indispensable power in the worldwide stem cell research field. This review mainly focuses on the research progress in stem cells and regenerative medicine in our country since the advent of induced pluripotent stem cell technology, including induced pluripotent stem cells, transdifferentiation, haploid stem cells, and new gene editing tools.
Cell Transdifferentiation
;
Humans
;
Induced Pluripotent Stem Cells
;
Pluripotent Stem Cells
;
Regenerative Medicine
;
trends
;
Stem Cells
7.Induction and differentiation of induced pluripotent stem cells into macrophages: a review.
Xinchun YANG ; Xiaolong WU ; Jinlian HUA
Chinese Journal of Biotechnology 2021;37(11):4001-4014
Induced pluripotent stem cells (iPSCs) are a type of cells similar to embryonic stem cells but produced by reprogramed somatic cells. Through in vitro differentiation of iPSCs, we can interrogate the evolution history as well as the various characteristics of macrophages. iPSCs derived macrophages are not only a good model for drug screening, but also an important approach for immunotherapy. This review summarizes the advances, challenges, and future directions in the field of iPSCs-derived macrophages.
Cell Differentiation
;
Embryonic Stem Cells
;
Induced Pluripotent Stem Cells
;
Macrophages
8.Application of Induced Pluripotent Stem Cells in Rheumatology.
Journal of Rheumatic Diseases 2013;20(5):286-296
Since induced pluripotent stem cell (iPSC) was first introduced by Yamanaka in 2006, it took only six years to win a Nobel Prize for his pioneering work. It is unusual to win a Nobel Prize for such recent research with a short history. Many scientists and clinicians are interested in iPSC for its potential application. Significant progression in this field has been made, while there remain many hurdles to overcome for application of iPSC technique in real clinics. In this review, the concept of reprogramming and the basic techniques of iPSC generation will be discussed for the reader's convenience, followed by discussion of recent progress, followed by the topics of "disease modeling" and "cell therapy" with iPSC in the second half of this article. Several examples of rheumatologic application of iPSC will be provided in the main text. If rheumatologists could understand the merits and potentials of iPSC, opportunities for innovative research and therapy can be expanded.
Arthritis, Rheumatoid
;
Induced Pluripotent Stem Cells*
;
Lentivirus
;
Nobel Prize
;
Osteoarthritis
;
Pluripotent Stem Cells
;
Rheumatology*
9.Disease-specific pluripotent stem cells.
Korean Journal of Pediatrics 2010;53(8):786-789
Induced pluripotent stem (iPS) cells are generated by epigenetic reprogramming of somatic cells through the exogenous expression of transcription factors. Recently, the generation of iPS cells from patients with a variety of genetic diseases was found to likely have a major impact on regenerative medicine, because these cells self-renew indefinitely in culture while retaining the capacity to differentiate into any cell type in the body, thereby enabling disease investigation and drug development. This review focuses on the current state of iPS cell technology and discusses the potential applications of these cells for disease modeling; drug discovery; and eventually, cell replacement therapy.
Epigenomics
;
Humans
;
Induced Pluripotent Stem Cells
;
Pluripotent Stem Cells
;
Regenerative Medicine
;
Transcription Factors
10.Culture of pluripotent stem cell-derived hepatocytes and organoids.
Chinese Journal of Hepatology 2022;30(3):244-248
Liver is one of the most important organs in the human body. Liver diseases are also a major threat to human health and longevity. Hepatic decompensation treatment is quite difficult due to multiple reasons. Extracorporeal liver support devices are unable to solve this problem, and there is a severe shortage of orthotopic liver transplant donors. Study of pluripotent stem cell-derived hepatocytes and organoids can determine not only hepatocyte fate, but also liver development, regeneration mechanisms, and pathophysiology. Furthermore, it can be used for drug screening in order to provide a stable source of functional hepatocytes for future transplantation therapy. Culture of pluripotent stem cell-derived hepatocytes and organoids has a self-organizing process similar to liver development, i.e., starting with changes in several key factors, and eventually forming functionally complex cells/organs. This paper introduces the main methods and progress of pluripotent stem cell-derived hepatocytes and organoids, with hope to provide clues for future research.
Cell Differentiation
;
Hepatocytes
;
Humans
;
Induced Pluripotent Stem Cells
;
Liver
;
Organoids
;
Pluripotent Stem Cells